feed,title,long_url,short_url
r/covid19:2+,"[Preprint] A two-arm, randomized, controlled, multi-centric, open-label Phase-2 study to evaluate the efficacy and safety of Itolizumab in moderate to severe ARDS patients due to COVID-19",https://redd.it/k5tto0,
